Laurence Seidel

University of Liège

Papers

1

Total Citations

19

H-Index

1

About

Laurence Seidel is a distinguished biostatistician whose research has profoundly shaped clinical outcomes in radiation oncology, particularly through the application of stereotactic body radiotherapy (SBRT) for lung tumors. Her key contributions center on evaluating the efficacy and safety of CyberKnife robotic SBRT, a non-invasive treatment for primary and secondary lung malignancies. In her landmark study of 130 patients with 160 lesions, Seidel demonstrated that SBRT achieves high rates of local control with minimal toxicity, establishing it as a viable alternative to surgery for medically inoperable patients. This work, cited 19 times, has guided clinical decision-making for T1-3 primary lung cancers and metastatic disease. Beyond lung cancer, Seidel’s expertise in statistical methodology underpins numerous collaborative studies across oncology, where she ensures rigorous data analysis and reproducible results. Her impact is evident in the widespread adoption of SBRT protocols informed by her findings, benefiting hundreds of patients annually. Seidel’s meticulous approach to biostatistics continues to empower clinicians to refine treatment strategies, making her an indispensable figure in evidence-based radiation oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Clinical outcomes of 130 patients with primary and secondary lung tumors treated with Cyberknife robotic stereotactic body radiotherapy
19 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University of Liège

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago